Corporate$AZN6:34 AM ET

AstraZeneca shares rise 3.9% after cost-cutting plan, analyst says

By BORSA NewsroomPublished Oct 30, 2026, 6:34 AM EDTUpdated Oct 30, 2026, 6:34 AM EDT

AstraZeneca shares jumped 3.9% after the UK drugmaker announced cost-cutting plans to free up cash for new drug investment. AJ Bell analyst Russ Mould said investors are giving the company credit for being proactive after recent trial setbacks. CEO Pascal Soriot appears to be trying to reassure the market.

Sentimentbullish 70

Bullish · 70 of 100

Impact40

low · stays off the top drivers

Confidence90%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

AstraZeneca shares rose 3.9%
Company announced cost-cutting plans